TABLE 1.
Study group (source, phase of measles infection) | Time after onset of rash | Total no. of samples | Mean % (range) of isolates seropositive fora:
|
|||
---|---|---|---|---|---|---|
IgG1 | IgG2 | IgG3 | IgG4 | |||
1a (natural, acute) | 0-7 days | 32 | 94 (87-100) | 34 (27-41) | 44 (37-51) | 50 (40-54) |
2a (postvaccinal, acute) | 0-7 days | 15 | 100 (89-100) | 13 (2-24) | 40 (29-51) | 68 (56-78) |
1b (natural, convalescence) | 8-26 days | 22 | 100 (91-100) | 64 (55-73) | 72 (63-81) | 96 (87-100) |
2b (postvaccinal, convalescence) | 8-30 days | 13 | 100 (88-100) | 54 (42-66) | 70 (58-82) | 92 (80-100) |
3 (natural, long-lasting immunity) | 10-80 years | 100 | 100 (94-100) | 2 (0-8) | 3 (0-9) | 86 (80-92) |
4 (postvaccinal, long-lasting immunity) | 8-12 years | 76 | 100 (93-100) | 2 (0-9) | 7 (0-13) | 9 (2-16) |
95% CI.